ArticleScientific reports2017

NMDA receptor antagonism with novel indolyl, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, reduces seizures duration in a rat model of epilepsy.

Hussin A Rothan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.